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The Problem-Acute Respiratory Failure in 
Chronic Obstructive Pulmonary Disease. In a 
recent review the authors comment on acute re-
spiratory failure complicating chronic obstructive 
pulmonary disease. They state that because of 
the tolerance to chronic hypoxemia, the recur-
rent nature of the Jung failure, and the increased 
number of complications during mechanicai ven-
tilation, "artificial ventilation is not indicated un-
til all other attempts have failed to reverse hy-
poxemia without causing hypocapnia" ( 2). 
This paper will detail the conservative man-
agement of acute respiratory failure in patients 
with chronic respiratory failure due to chronic 
bronchitis and emphysema. It is important to rec-
ognize that this is a very specific group of patients. 
They have had chronic hypoxia and hypercarbia 
for months or years preceding their current episode 
of acute respiratory failure. There occurs a further 
drop in arterial P0 , (Pa0 ,) and usually a further 
rise in arterial Pco, (Pac0 ,). The baseline arterial 
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Because of infection, sedation, heart failure, as-
sociated asthma, and so forth, they usually pre-
* Presented by Dr. Hunt at the Symposium on Respira-
tory Failure, May 26, 1972, at Richmond, Virginia. 
1 The ventimask can be obtained from The Bethlehem 
Corporation, 225 W. Second Street, Bethlehem, Pennsyl-
vania. 
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sent to their physician with increasing dyspnea, 
cyanosis, disorientation, and commonly the fol-
lowing arterial gases and pH: 
Pao, 40 mm Hg 
Paco, = 55 mm Hg 
pH = 7.35 
Remember that the statements in this paper do 
not apply to asthma, only to chronic bronchitis and 
emphysema. 
The Therapeutic Goal. The physician must 
increase the Pa0 , "significantly" with "little in-
crease" in Paco, and ''little decrease" in pH. While 
this stopgap measure keeps the patient alive, thera-
peutic efforts are directed toward complicating 
diseases responsible for the acute respiratory failure. 
An attempt will be made to define the vague term 
"significant decrease" in Pa0 ,, and " little decrease" 
in pH. 
The Tool-'the Ventimask.1 Since this group 
of patients has had an elevated Paco, for varying 
periods of time, ventilation is keyed to the low 
-arterial -oxygen, rather than to the C02 partial 
pressure. The usual methods of oxygen delivery, the 
nasal catheter and face mask, deliver 30% to 40% 
oxygen, enough to lethally depress ventilation. 
The ventimask represents a method by which 
the physician can deliver low flow oxygen inexpen-
sively and with safety. Because of the Venturi effect, 
the 100% oxygen that flows into the mask will entrain 
room air (21 % 0 2) through the side ports of the 
mask (fig. I). Four liters of oxygen flow per minute 
is necessary to achieve the 24% 0 2 concentration in 
the mask. However, further increases in flow will 
merely draw more 21% oxygen into the mask, and 
by clever engineering the oxygen concentration in 




Fig. 1-The 24% ventimask. 
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ventimask is similar in all respects except that the 
final F1 0 , is 28%. 
Guidelines for Arterial Gases. 
Arterial Oxygen. When the Pa 0 , falls below 
50 mm Hg, pulmonary capillary vasoconstriction 
occurs, and pulmonary hypertension occurs or is 
accentuated. Pa 0 , below 40 will decrease sodium and 
free water excretion and may depress ventilation . 
In this range (40 or below) digitalis intoxication is 
markedly accentuated and ventricular arrhythmias 
occur. 
In practice then, the immediate goal of therapy 
should be to increase the Pa 0 , from 30- 40 mm Hg 
to the 45- 55 mm Hg range. This frequently can be 
done with the 24% ventimask, remembering that an 
increase in inspired oxygen concentration (F1 0 ,) 
from 21% (room air) to 24% is really 3% of an 
atmosphere (760 mm Hg) or approximately 21 mm Hg. 
Since in patients with chronic bronchitis and em-
physema ventilation is usually reduced to many 
alveoli, the alveolar 0 2 (Pa 0 ,) of 128 mm Hg (as in 
fig. l) is usually reduced so that the increase m 
Pa0 , is more like lO mm Hg than 21 mm Hg. 
But it is very important to note that this lO 
mm Hg change in Pa 0 , is on the steep portion of the 
oxyhemoglobin dissociation curve (fig. 2) and will 
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actually nearly double the oxygen delivered at the 
tissue level. 
Guidelines for Paco, and pH. Except for its 
narcotic properties, Paco, elevation per se is probably 
not important but may be used as a guide to oxygen 
delivery. If the 24% ventimask therapy results in a 
lO mm Hg increase in Pa 0 , and at the same time 
elevates the Paco, greater than 5 mm Hg, further 
increase in oxygen concentration should not be 
attempted. If the Paco, remains the same or is 
reduced then one can safely go on to a 28% ventimask 
and another 4% (28 mm Hg) increase in F10 , . A 
Paco, greater than 65 mm Hg may decrease salt and 
free water excretion, but this can usually be overcome 
with the use of diuretics (Lasix® not ethacrynic acid). 
The pH, however, is critical. Many vital en-
zyme systems do not work as the pH falls below 
7 .2, and hydrogen ion elevation will also cause 
pulmonary capillary vasoconstriction. 
If the pH can be kept between 7 .3 and 7 .4 
and does not remain consistently below 7.2, and 
if the patient remains conscious and able to cough, 
then conservative therapy should be continued. 
General Measures. Dr. E. J. M. Campbell 
has said, "controlled oxygen therapy plus inef-
fectual nursing is better than uncontrolled oxygen 
plus ineffectual nursing only because the patient 
gets into less trouble" ( 1). The most impor-
tant factor immediately is nursing care. 
The patient should be: 
1. In a chair, not flat in bed. 
2. In a lighted room or corridor for the first 
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Fig. 2-Increase in Pa .. , on 24% ventimask. "Available" 
means available at the tissue level (modified after Camp-
bell) . 
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3. Receiving chest physiotherapy each hour 
from the floor nurse or relatives or at least 
encouraged to cough and breathe deeply 
every 15 minutes. 
4. Encouraged to use a pressure regulated 
IPPB machine (Bird or Bennett) five 
minutes out of every 30 or 60 minutes 
(without Isuprel®) . This is for "stir-up," 
cough, and stimulation not specifically for 
ventilation. 
Specific Therapy. In general, there is no 
"specific therapy" for chronic bronchitis . and ei_n-
physema, so that complications or associated dis-
eases must be diligently searched for and vig-
orously treated if present. One must not blindly 
and mindlessly treat each patient with chronic 
bronchitis and emphysema with digitalis, antibi-
otics, diuretics, steroids, and broncholytic agents. 
Mucolytics. There are none that are effective. 
Acetyl cysteine (Mycomyst® ) may actually ag-
gravate any bronchospasm that may be present. 
Robitussin® should be reserved for your grand-
mother who has a " tickle in her throat." 
Look for and treat : 
1. Left ventricular failure . This is most eas-
ily diagnosed by an upright chest x-ray showing 
pulmonary venous engorgement in the upper lobes 
or Kerley B lines (fig. 3). Obvious pulmonary 
edema, whether unilateral or mild, should be 
suspected and searched for . Treat vigorously with 
Lasix® and replace K losses with KC! not K-Trip-
lex. Digoxin should be used judiciously. The right 
ventricle will respond to digitalis, but toxicity may 
occur at half the usual digoxin level when the 
Pa0 , is below 50 mm Hg. 
2. Asthma. Eosinophils in the blood or on 
Hansel stain2 of the sputum suggest a diagnosis 
of asthma. Suspect this diagnosis if the patient 
does not smoke, is under 50, or has a childhood 
history of asthma. If asthma is not present, Isup-
rel® can accentuate hypoxemia and in the already 
hypoxemic individual, aminophylline, adrenalin, 
and ephedrine may cause dangerous arrhythmias. 
In the patient with chronic bronchitis and emphy-
sema in respiratory failure without prior evidence 
of a good response, certainly Isuprel® and prob-
2 Hansel stain may be obtained from Lide Laboratories, 
6828 Oakland Avenue, St. Louis, Mo. 63139-$7.50 for 8 
ounces. 
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Fig. 3-The arrows indicate the position of Kerley B lines. 
The pulmonary veins are shown in black. 
ably the other bronchodilator drugs are contra-
indicated. 
Steroid therapy (prednisone 40-60 mg daily) 
in patients with associated asthma may be life 
saving. An intermediate PPD should be done on 
every patient on admission prior to the insti-
tution of steroids and, if positive, isoniazid ther-
apy should be considered, depending on the du-
ration of the steroid therapy and the appearance 
of the chest x-ray. 
3. Infection. The sputum should be observed, 
stained (both Gram and Hansel), and cultured 
if grossly purulent. Infrequently, grossly purulent 
sputum can be due to the presence of eosinophils 
alone. Usually acute purulent bronchitis is the 
the cause. The most common pathogens found are 
the pneumococcus or hemophilus influenza. Since 
probably 10% of all strains of streptococcus pneu-
monia are resistant to tetracycline, ampicillin 2 g 
daily is the treatment of choice (unless penicil-
lin sensitivity is present). 
4 . Pneumonia: A chest x-ray must be ob-
tained. The use of a stethoscope alone in the exam-
ination of the emphysematous chest is grossly 
inadequate. The presence of pneumonia in the pa-
tient with acute respiratory failure constitutes a 
medical emergency. Unless the overwhelmingly 
predominant organism can be identified by gram 
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stain and quellung3 as a pneumococcus, ceph-
alothin and gentamycin should be used for 48 
hours until the results of the sputum culture are 
available. You do not have time to be wrong, 
then switch. 
5. Cor pulmonale. Rapid, effective, specific 
therapy for the right heart failure of cor pul-
monale in these patients is not available. The pa-
tient has right heart failure primarily because he 
is hypoxemic, and you cannot rapidly relieve his 
hypoxemia or he will underventilate, become un-
conscious, needing intubation and mechanical 
ventilation, and this is what you are trying to 
avoid. As mentioned above, digitalis will improve 
the function of the right ventricle but must be 
used cautiously. If the patient has not been given 
digitalis in the past, digoxin 0.25 mg daily with-
out a loading dose is the preferable technique. 
A reduction in pulmonary blood volume, ascites, 
and pleural effusion all may improve pulmonary 
function so that aggressive diuretic therapy may 
be indicated. Ethacrynic acid may produce un-
derventilation and should be avoided. Currently 
Lasix® is the drug of choice. Thoracentesis may 
produce a lethal pneumothorax and should be 
avoided unless a massive efjusion is present. There 
is no evidence that phlebotomy is an effective 
method of therapy under these circumstances. 
Sedation. If over sedation with morphine or 
pentazocine is suspected, naloxone (narcan) is spe-
cific therapy and can be given without risk of further 
sedation. If other drugs (Valium®, meprobamate, and 
so forth) are known to have been primarily respon-
sible for the respiratory depression, then it be-
comes even more imperative that vigorous at-
tempts be made to keep the patient awake for the 
first 24 hours of therapy. It should be noted here 
that it is self-defeating to keep patients awake 
continuously for more than 24 hours. At the end 
of that time, alternating naps with arousal every 
30 minutes to one hour becomes necessary. 
3 Quellung reagent may be obtained as "Omniserum" 
from Statens Seruminstitute, Amager Boulevard 80, DK-
2300, Copenhagen S, Denmark. 
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When to Intubate. Reduced consciousness 
and an inability to cough are the major indica-
tions for intubation and ventilation. Inability to 
achieve an arterial Pa 0 , greater than 30 mm Hg 
or maintain a pH greater than 7 .2 after 24 hours 
of therapy are relative indications for intubation. 
But, one should never act precipitously on a sin-
gle number obtained from the laboratory that 
does not fit the clinical course that has been ob-
served. 
Emergency tracheostomy should never be 
done without prior intubation. Ideally a period of 
mechanical ventilation with achievement of good 
oxygenation and reversal of the respiratory aci-
dosis should be accomplished prior to tracheos-
tomy. 
Summary. Low flow oxygen therapy should 
be given a trial in all conscious patients presenting 
with acute respiratory failure due to chronic bron-
chitis and emphysema. The tolerance of these 
patients to hypoxemia and hypercarbia make this 
means of therapy possible. The ventimask is an 
effective, inexpensive method of administering low 
flow oxygen, with the added attraction that the 
oxygen concentration cannot be inadvertently in-
creased. Nursing care and aggressive therapy of 
complicating or associated medical problems are 
the key to successful management. 
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